Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
34.25 EUR | +0.74% | +1.78% | -14.72% |
Feb. 02 | Boiron: nearly 600,000 shares tendered to the OPAS | CF |
Jan. 11 | Boiron: OPAS open from January 11 to 31 | CF |
Business Summary
Homeopathic medicines are obtained from substances called homeopathic strains, according to a manufacturing process described in the pharmacopoeia. These strains can be of plant, animal, mineral or chemical origin.
There are two main families of homeopathic medicines: common name homeopathic medicines and brand name homeopathic medicines (specialties).
BOIRON group centralizes its production and logistics in France. It also has 26 wholly-owned or leased distribution facilities in France and various offices in the countries where it has subsidiaries.
Net sales are distributed geographically as follows: France (52.4%), Europe (22.5%), North America (22.6%) and other (2.5%).
Number of employees: 2,813
Sales per Business
EUR in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
Homeopathic Specialties
52.4
%
| 258 | 56.7 % | 280 | 52.4 % | +8.38% |
Common Name Homeopathic Medicines
34.6
%
| 195 | 42.8 % | 185 | 34.6 % | -5.28% |
Other Health Products
13.1
%
| 2 | 0.5 % | 70 | 13.1 % | +3,171.80% |
Sales per region
EUR in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
France
52.4
%
| 254 | 55.8 % | 280 | 52.4 % | +10.21% |
North America
22.6
%
| 84 | 18.4 % | 121 | 22.6 % | +43.71% |
Europe
22.5
%
| 109 | 23.8 % | 120 | 22.5 % | +10.87% |
Other Countries
2.5
%
| 9 | 1.9 % | 13 | 2.5 % | +53.99% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 55 | 11-06-30 | |
Thierry Boiron
CHM | Chairman | 63 | 96-09-17 |
Frédéric Riou
CTO | Chief Tech/Sci/R&D Officer | - | - |
Isabelle Chanel
CTO | Chief Tech/Sci/R&D Officer | - | - |
Hervé Coulpier
CTO | Chief Tech/Sci/R&D Officer | - | 17-04-30 |
Patrice Varraut
COO | Chief Operating Officer | - | 08-12-31 |
Fabrice Rey
IRC | Investor Relations Contact | - | - |
Juliette Baudry
HRO | Human Resources Officer | - | - |
Frédéric Ducher
LAW | General Counsel | - | 15-05-31 |
Eric Lambert
SEC | Corporate Secretary | - | 19-05-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 80 | 03-05-21 | |
Thierry Boiron
CHM | Chairman | 63 | 96-09-17 |
Jacky Abécassis
BRD | Director/Board Member | 79 | 87-05-05 |
Michéle Boiron
BRD | Director/Board Member | 79 | 96-09-17 |
Director/Board Member | 52 | 10-03-09 | |
Chief Executive Officer | 55 | 11-06-30 | |
Anne Borfiga
BRD | Director/Board Member | 52 | 21-05-26 |
Grégory Walter
BRD | Director/Board Member | 46 | 17-05-17 |
Laurence Boiron
BRD | Director/Board Member | 49 | 20-05-27 |
Director/Board Member | 53 | 21-12-08 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 17,545,408 | 2,265,995 ( 12.92 %) | 183,225 ( 1.044 %) | 12.92 % |
Company contact information
Group companies
Name | Category and Sector |
---|---|
Boiron Laboratories Pvt Ltd.
|
Sector
Sales per Business
Sales per region
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-15.46% | 631M | |
+38.08% | 6.05B | |
-16.43% | 4.45B | |
-12.46% | 3.06B | |
-0.21% | 3.04B | |
-0.59% | 2.58B | |
+34.54% | 1.79B | |
+0.93% | 1.66B | |
-10.63% | 1.63B | |
-12.50% | 1.54B |
- Stock Market
- Equities
- BOI Stock
- Company BOIRON